Search for Clinical Trial Results

Sponsored By

Lymphoma, Primary Cutaneous Anaplastic Large Cell - 8 Studies Found

Status Study
Withdrawn Study Name: MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma
Condition: Lymphoma, Large-Cell
Date: 2006-03-01
Interventions: Drug: MDX-060
Completed Study Name: Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma
Condition: Large Cell Lymphoma
Date: 2004-12-10
Interventions: Drug: SGN-30
Active, not recruiting Study Name: A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Patients With CD30-Positive Cutaneous T-Cell Lymphoma
Condition:
  • Primary Cutaneous Anaplastic Large Cell Lymphoma
  • Mycosis Fungoi
    Date: 2012-03-27
    Interventions:
    • Drug: Brentuximab Vedotin Bren
Completed Study Name: Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
Condition:
  • Cutaneous T-cell Lymphoma
  • Mycosis Fungoides
  • Sezary Syndrom
    Date: 2010-05-28
    Interventions:
    • Drug: Pralatrexate Injection

Active, not recruiting Study Name: SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)
Condition:
  • CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma
  • Lymphoma, Pr
    Date: 2011-05-10
    Interventions: Drug: SGN-35 1.8 mg/kg administered by outpatient IV infusion given over approximately 30 minutes on Day
Recruiting Study Name: Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma
Condition:
  • Adult Nasal Type Extranodal NK/T-Cell Lymphoma
  • Adult T-Cell Leukemia/Lymphoma
  • Date: 2016-01-08
    Interventions:
    • Other: Laboratory Biomarker Analysis

Recruiting Study Name: Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency
Condition:
  • Aggressive Non-Hodgkin Lymphoma
  • Anaplastic Large Cell Lymphoma
  • Dietary Supplement: Cholecalciferol

Recruiting Study Name: Multicentre Phase I Trial of Engineered T Cells for Patients With Relapsed or Refractory Primary Cutaneous CD30+ Large T Cell Lymphoma or Transformed CD30+ Mycosis Fungoides
Condition:
  • CD30 Positive Cutaneous T Cell Lymphoma
  • CD30 Positive Transformed Mycosis Fungoides
    • Date: 2012-07-11
    Interventions: Genetic: Genetically modified T cells # 1138